financetom
Business
financetom
/
Business
/
Eli Lilly to buy cancer drug developer Scorpion Therapeutics for $2.5 billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eli Lilly to buy cancer drug developer Scorpion Therapeutics for $2.5 billion
Jan 13, 2025 6:28 AM

(Reuters) - Eli Lilly ( LLY ) said on Monday it would acquire cancer therapy developer Scorpion Therapeutics for $2.5 billion in cash.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SingTel's profit rises on boost from Aussie unit Optus and IT ops; shares gain
SingTel's profit rises on boost from Aussie unit Optus and IT ops; shares gain
Aug 14, 2024
(Reuters) -Singapore Telecommunications posted a 5.4% rise in its first-quarter profit on Thursday, driven by strong performance in its domestic and Australian telecom operations, as well as in its IT business, sending its shares to a two-week high. Operating earnings for its Australian telecom unit Optus rose 4.2% to S$475 million ($360.59 million), helped by price increases in postpaid plans...
Profits for Colombia's Grupo Aval up 23% in second quarter
Profits for Colombia's Grupo Aval up 23% in second quarter
Aug 14, 2024
BOGOTA, Aug 14 (Reuters) - Colombian financial conglomerate Grupo Aval reported on Wednesday a nearly 23% rise in its second-quarter net profit, climbing to 204.3 billion Colombian pesos ($50.9 million). Meanwhile, the company's interest income between April and June was up by about 22% to total 1.9 trillion pesos, according to its quarterly results report. The boost was driven by...
Australian telco firm Telstra's annual profit dips but forecasts brighter 2025, boosting shares
Australian telco firm Telstra's annual profit dips but forecasts brighter 2025, boosting shares
Aug 14, 2024
(Reuters) -Top Australian telco Telstra said annual profit sank 13% as it wrote down the value of its fixed-line enterprise unit and counted the cost of laying off up to 2,800 employees, but it flagged higher earnings in the year ahead, sending shares up. Telstra shares rose 2.7% to A$3.975 as at 0148 GMT to hit their highest level in...
EY, KPMG benefit most from PwC China's regulatory woes
EY, KPMG benefit most from PwC China's regulatory woes
Aug 14, 2024
HONG KONG (Reuters) - Ernst & Young (EY) and KPMG have snapped up over half of PwC's corporate clients in China that have fled the market's leading accounting firm as it faces a regulatory probe, filings show. Chinese authorities have been investigating PwC's role in auditing China Evergrande Group ( EGRNF ), after the securities regulator accused the troubled property...
Copyright 2023-2026 - www.financetom.com All Rights Reserved